| Price and Chart delayed at least 15 mintues. |
|
Price
$ 45.00
|
Change
0.00
|
|
Open
0.00
|
% Change
0.0%
|
|
Prev Close
45.00
|
Volume
NA
|
|
Market Value
13 bil
|
P/E Ratio
15.3
|
|
Bid
43.02
|
EPS
2.94
|
|
Ask
46.00
|
Dividend
0.00
|
|
High
0.00
|
Yield
0.0
|
|
Low
0.00
|
Shares Out
289 mil
|
|
52wk High
73.59
|
52wk Low
37.21
|
|
Industry: Biotechnology
|
|
Sector: Healthcare
|
BIIB Profile
A biotechnology company, which is engaged in the discovery, development, manufacturing and commercialization of innovative therapies.
Biogen IDEC, Inc.
14 Cambridge Center
Cambridge, MA 02142
Phone: (617) 679-2000
Fax: (617) 679-2617
Web Site: www.biogenidec.com
BIIB Wires Headlines
|
|
| 07.02.09 |
|
Final Glance: Biotechnology companies
|
|
| 07.02.09 |
|
Midday Glance: Biotechnology companies
|
|
| 07.02.09 |
|
Early Glance: Biotechnology companies
|
|
| 07.01.09 |
|
Final Glance: Biotechnology companies
|
|
| 07.01.09 |
|
AIG, General Mills, MetroPCS are big movers
|
More BIIB From Wires Headlines >
Forbes.com on BIIB RSS
- Betting On A Cruel Summer For Biogen
- Biogen options action points to further near-term price declines.
Investopedia on BIIB
|